Go to Page # Page of 36
loading

Anti-Minor Histocompatibility Antigen Immunotherapy

 Denis Claude Roy MD
  17th-Aug-2018
Description: GVTE is mediated by donor T cells that recognize MiHAs on leukemic cells.
Views: 4520
Domain: Medical
Category: Therapy
Contributing Organization: CBMTG
 ‐ More of their Presentations
Contents:
Anti-Minor Histocompatibility
Antigen
Immunotherapy
Denis Claude Roy, MD
CEO, CellCAN
CSO, C3i
Director of Research,
Hôpital Maisonneuve-Rosemont
Professor of Medicine, Université de Montréal

CBMTG Annual Meeting
June 7, 2018, Ottawa

2

CELL therapy for cancer

Allogeneic Hematopoietic
Cell Transplantation
(AHCT)
• One of the most important medical
breakthrough of the ... See more

Recent Presentations

...
21 September, 2019
Yoojin Oh
20 September, 2019
...
19 September, 2019